PT845991E - Utilizacao de difosfonatos substituidos com fenol como agentes anti-neoplasicos - Google Patents
Utilizacao de difosfonatos substituidos com fenol como agentes anti-neoplasicosInfo
- Publication number
- PT845991E PT845991E PT96928381T PT96928381T PT845991E PT 845991 E PT845991 E PT 845991E PT 96928381 T PT96928381 T PT 96928381T PT 96928381 T PT96928381 T PT 96928381T PT 845991 E PT845991 E PT 845991E
- Authority
- PT
- Portugal
- Prior art keywords
- pct
- difosphonates
- phenol
- utilization
- substituted
- Prior art date
Links
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical group OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 title 1
- 229940034982 antineoplastic agent Drugs 0.000 title 1
- 239000002246 antineoplastic agent Substances 0.000 title 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000001613 neoplastic effect Effects 0.000 abstract 1
- 230000009466 transformation Effects 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4025—Esters of poly(thio)phosphonic acids
- C07F9/404—Esters of poly(thio)phosphonic acids containing hydroxy substituents in the hydrocarbon radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH02213/95A CH690163A5 (fr) | 1995-07-28 | 1995-07-28 | Dérivés gem-diphosphonates substitués utiles en tant qu'agents anti-cancers. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT845991E true PT845991E (pt) | 2002-07-31 |
Family
ID=4228513
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT96928381T PT845991E (pt) | 1995-07-28 | 1996-07-26 | Utilizacao de difosfonatos substituidos com fenol como agentes anti-neoplasicos |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6127350A (pt) |
| EP (1) | EP0845991B1 (pt) |
| JP (1) | JPH11511127A (pt) |
| CN (1) | CN1091601C (pt) |
| AT (1) | ATE212847T1 (pt) |
| AU (1) | AU723094B2 (pt) |
| CA (1) | CA2228212A1 (pt) |
| CH (1) | CH690163A5 (pt) |
| DE (1) | DE69619117T2 (pt) |
| DK (1) | DK0845991T3 (pt) |
| ES (1) | ES2172675T3 (pt) |
| HK (1) | HK1015686A1 (pt) |
| PT (1) | PT845991E (pt) |
| WO (1) | WO1997004785A1 (pt) |
| ZA (1) | ZA966364B (pt) |
Families Citing this family (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9603637D0 (en) * | 1996-02-21 | 1996-04-17 | Smithkline Beecham Plc | Process |
| US6555529B1 (en) | 1997-12-25 | 2003-04-29 | Toray Industries, Inc. | Remedies for intramedullary diseases |
| AU785355B2 (en) | 1999-12-03 | 2007-02-01 | Regents Of The University Of California At San Diego, The | Phosphonate compounds |
| GB0019272D0 (en) * | 2000-08-04 | 2000-09-27 | Symphar Sa | Pharmaceutical compounds |
| WO2003008425A1 (fr) | 2001-07-16 | 2003-01-30 | Universite Paris 13 | Nouveaux derives de bisphosphonates, leurs preparations et utilisations |
| FR2827289B1 (fr) * | 2001-07-16 | 2004-07-23 | Univ Paris 13 | Nouveau derive d'acide diphosphonique, son application en therapeutique et procede de preparation |
| JP2005511526A (ja) * | 2001-10-18 | 2005-04-28 | イレックス プロダクツ インコーポレイテッド | ジホスホネート誘導体による皮膚の治療方法 |
| AU2003232108A1 (en) * | 2002-05-11 | 2003-11-11 | Ilex Products, Inc. | 1,1- and 1,2-bisphosphonates as apoliprotein e modulators |
| US20040132802A1 (en) * | 2002-09-03 | 2004-07-08 | Jackie Butler | Pharmaceutical formulations and methods for modified release of statin drugs |
| WO2004026242A2 (en) * | 2002-09-19 | 2004-04-01 | Ilex Oncology Research, Sarl | Substituted ketophosphonate inhibitors of tumor cell proliferation |
| ATE550019T1 (de) | 2005-05-17 | 2012-04-15 | Merck Sharp & Dohme | Cis-4-ä(4-chlorophenyl)sulfonylü-4-(2,5- difluorophenyl)cyclohexanepropansäure zur behandlug von krebs |
| GB0603041D0 (en) | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
| EP2083831B1 (en) | 2006-09-22 | 2013-12-25 | Merck Sharp & Dohme Corp. | Method of treatment using fatty acid synthesis inhibitors |
| US20110218176A1 (en) | 2006-11-01 | 2011-09-08 | Barbara Brooke Jennings-Spring | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
| EA016079B1 (ru) | 2007-01-10 | 2012-01-30 | Институто Ди Ричерке Ди Биолоджиа Молеколаре П. Анджелетти Спа | Амидзамещенные индазолы в качестве ингибиторов поли(adp-рибоза)полимеразы (parp) |
| EP2132177B1 (en) | 2007-03-01 | 2013-07-17 | Novartis AG | Pim kinase inhibitors and methods of their use |
| BRPI0812159A2 (pt) | 2007-05-21 | 2017-05-02 | Novartis Ag | inibidores de csf-1r, composições e métodos de uso |
| JP5501227B2 (ja) | 2007-06-27 | 2014-05-21 | メルク・シャープ・アンド・ドーム・コーポレーション | ヒストンデアセチラーゼ阻害剤としての４−カルボキシベンジルアミノ誘導体 |
| US8691825B2 (en) | 2009-04-01 | 2014-04-08 | Merck Sharp & Dohme Corp. | Inhibitors of AKT activity |
| WO2010144909A1 (en) | 2009-06-12 | 2010-12-16 | Novartis Ag | Fused heterocyclic compounds and their uses |
| PE20121172A1 (es) | 2009-10-14 | 2012-09-05 | Merck Sharp & Dohme | Piperidinas sustituidas con actividad en la hdm2 |
| AU2010343102B2 (en) | 2009-12-29 | 2016-03-24 | Dana-Farber Cancer Institute, Inc. | Type II Raf kinase inhibitors |
| AU2011227643A1 (en) | 2010-03-16 | 2012-09-20 | Dana-Farber Cancer Institute, Inc. | Indazole compounds and their uses |
| EP2584903B1 (en) | 2010-06-24 | 2018-10-24 | Merck Sharp & Dohme Corp. | Novel heterocyclic compounds as erk inhibitors |
| US8518907B2 (en) | 2010-08-02 | 2013-08-27 | Merck Sharp & Dohme Corp. | RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) |
| RU2745848C2 (ru) | 2010-08-17 | 2021-04-01 | Сирна Терапьютикс, Инк. | ОПОСРЕДУЕМОЕ РНК-ИНТЕРФЕРЕНЦИЕЙ ИНГИБИРОВАНИЕ ЭКСПРЕССИИ ГЕНОВ ВИРУСА ГЕПАТИТА B (HBV) С ПРИМЕНЕНИЕМ МАЛОЙ ИНТЕРФЕРИРУЮЩЕЙ НУКЛЕИНОВОЙ КИСЛОТЫ (миНК) |
| WO2012027236A1 (en) | 2010-08-23 | 2012-03-01 | Schering Corporation | NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS |
| WO2012030685A2 (en) | 2010-09-01 | 2012-03-08 | Schering Corporation | Indazole derivatives useful as erk inhibitors |
| US9242981B2 (en) | 2010-09-16 | 2016-01-26 | Merck Sharp & Dohme Corp. | Fused pyrazole derivatives as novel ERK inhibitors |
| EP2632472B1 (en) | 2010-10-29 | 2017-12-13 | Sirna Therapeutics, Inc. | Rna interference mediated inhibition of gene expression using short interfering nucleic acids (sina) |
| US9351965B2 (en) | 2010-12-21 | 2016-05-31 | Merck Sharp & Dohme Corp. | Indazole derivatives useful as ERK inhibitors |
| WO2012145471A1 (en) | 2011-04-21 | 2012-10-26 | Merck Sharp & Dohme Corp. | Insulin-like growth factor-1 receptor inhibitors |
| WO2013063214A1 (en) | 2011-10-27 | 2013-05-02 | Merck Sharp & Dohme Corp. | Novel compounds that are erk inhibitors |
| JP6106685B2 (ja) | 2011-11-17 | 2017-04-05 | ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド | Ｃ−ｊｕｎ−ｎ−末端キナーゼ（ｊｎｋ）の阻害剤 |
| RS57140B1 (sr) | 2012-03-23 | 2018-07-31 | Array Biopharma Inc | Amorfna čvrsta disperzija za korišćenje u lečenju raka mozga |
| US20150299696A1 (en) | 2012-05-02 | 2015-10-22 | Sirna Therapeutics, Inc. | SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS |
| EP2900241B1 (en) | 2012-09-28 | 2018-08-08 | Merck Sharp & Dohme Corp. | Novel compounds that are erk inhibitors |
| WO2014063068A1 (en) | 2012-10-18 | 2014-04-24 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinase 7 (cdk7) |
| US9758522B2 (en) | 2012-10-19 | 2017-09-12 | Dana-Farber Cancer Institute, Inc. | Hydrophobically tagged small molecules as inducers of protein degradation |
| US10000483B2 (en) | 2012-10-19 | 2018-06-19 | Dana-Farber Cancer Institute, Inc. | Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereof |
| RS56680B1 (sr) | 2012-11-28 | 2018-03-30 | Merck Sharp & Dohme | Kompozicije i postupci za lečenje kancera |
| ES2707305T3 (es) | 2012-12-20 | 2019-04-03 | Merck Sharp & Dohme | Imidazopiridinas sustituidas como inhibidores de HDM2 |
| WO2014120748A1 (en) | 2013-01-30 | 2014-08-07 | Merck Sharp & Dohme Corp. | 2,6,7,8 substituted purines as hdm2 inhibitors |
| WO2015034925A1 (en) | 2013-09-03 | 2015-03-12 | Moderna Therapeutics, Inc. | Circular polynucleotides |
| US20160264551A1 (en) | 2013-10-18 | 2016-09-15 | Syros Pharmaceuticals, Inc. | Heteroaromatic compounds useful for the treatment of prolferative diseases |
| AU2014337044A1 (en) | 2013-10-18 | 2016-05-05 | Dana-Farber Cancer Institute, Inc. | Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7) |
| WO2015164604A1 (en) | 2014-04-23 | 2015-10-29 | Dana-Farber Cancer Institute, Inc. | Hydrophobically tagged janus kinase inhibitors and uses thereof |
| US10017477B2 (en) | 2014-04-23 | 2018-07-10 | Dana-Farber Cancer Institute, Inc. | Janus kinase inhibitors and uses thereof |
| JO3589B1 (ar) | 2014-08-06 | 2020-07-05 | Novartis Ag | مثبطات كيناز البروتين c وطرق استخداماتها |
| EP3209671B8 (en) | 2014-10-21 | 2019-07-31 | Council of Scientific and Industrial Research | Alkylidene phosphonate esters as p-glycoprotein inducers |
| CA2972239A1 (en) | 2014-12-23 | 2016-06-30 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinase 7 (cdk7) |
| CA2978518C (en) | 2015-03-27 | 2023-11-21 | Nathanael S. Gray | Inhibitors of cyclin-dependent kinases |
| AU2016276963C1 (en) | 2015-06-12 | 2021-08-05 | Dana-Farber Cancer Institute, Inc. | Combination therapy of transcription inhibitors and kinase inhibitors |
| CA2996978A1 (en) | 2015-09-09 | 2017-03-16 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinases |
| CN106986789B (zh) * | 2016-01-20 | 2019-07-16 | 中国人民解放军军事医学科学院生物医学分析中心 | 对苯二酚类化合物及其制备方法与在抗肿瘤或免疫调节中的应用 |
| JOP20190055A1 (ar) | 2016-09-26 | 2019-03-24 | Merck Sharp & Dohme | أجسام مضادة ضد cd27 |
| WO2018071283A1 (en) | 2016-10-12 | 2018-04-19 | Merck Sharp & Dohme Corp. | Kdm5 inhibitors |
| CA3058134A1 (en) | 2017-04-13 | 2018-10-18 | Aduro Biotech Holdings, Europe B.V. | Anti-sirp alpha antibodies |
| EP3706742B1 (en) | 2017-11-08 | 2023-03-15 | Merck Sharp & Dohme LLC | Prmt5 inhibitors |
| WO2019148412A1 (en) | 2018-02-01 | 2019-08-08 | Merck Sharp & Dohme Corp. | Anti-pd-1/lag3 bispecific antibodies |
| EP3833668A4 (en) | 2018-08-07 | 2022-05-11 | Merck Sharp & Dohme Corp. | PRMT5 INHIBITORS |
| US11981701B2 (en) | 2018-08-07 | 2024-05-14 | Merck Sharp & Dohme Llc | PRMT5 inhibitors |
| WO2024180169A1 (en) | 2023-03-02 | 2024-09-06 | Carcimun Biotech Gmbh | Means and methods for diagnosing cancer and/or an acute inflammatory disease |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH675422A5 (pt) * | 1988-03-31 | 1990-09-28 | Symphar Sa | |
| JPH0377894A (ja) * | 1989-08-18 | 1991-04-03 | Toray Ind Inc | メチレンジホスホン酸化合物 |
-
1995
- 1995-07-28 CH CH02213/95A patent/CH690163A5/fr not_active IP Right Cessation
-
1996
- 1996-07-26 PT PT96928381T patent/PT845991E/pt unknown
- 1996-07-26 CA CA002228212A patent/CA2228212A1/en not_active Abandoned
- 1996-07-26 AU AU67874/96A patent/AU723094B2/en not_active Ceased
- 1996-07-26 WO PCT/EP1996/003301 patent/WO1997004785A1/en active IP Right Grant
- 1996-07-26 DK DK96928381T patent/DK0845991T3/da active
- 1996-07-26 CN CN96196005A patent/CN1091601C/zh not_active Expired - Fee Related
- 1996-07-26 DE DE69619117T patent/DE69619117T2/de not_active Expired - Fee Related
- 1996-07-26 ES ES96928381T patent/ES2172675T3/es not_active Expired - Lifetime
- 1996-07-26 AT AT96928381T patent/ATE212847T1/de not_active IP Right Cessation
- 1996-07-26 JP JP9507232A patent/JPH11511127A/ja active Pending
- 1996-07-26 EP EP96928381A patent/EP0845991B1/en not_active Expired - Lifetime
- 1996-07-26 US US09/011,247 patent/US6127350A/en not_active Expired - Fee Related
- 1996-07-26 ZA ZA966364A patent/ZA966364B/xx unknown
-
1999
- 1999-02-26 HK HK99100780A patent/HK1015686A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE212847T1 (de) | 2002-02-15 |
| CH690163A5 (fr) | 2000-05-31 |
| ES2172675T3 (es) | 2002-10-01 |
| CA2228212A1 (en) | 1997-02-13 |
| AU723094B2 (en) | 2000-08-17 |
| EP0845991B1 (en) | 2002-02-06 |
| AU6787496A (en) | 1997-02-26 |
| EP0845991A2 (en) | 1998-06-10 |
| JPH11511127A (ja) | 1999-09-28 |
| US6127350A (en) | 2000-10-03 |
| ZA966364B (en) | 1997-02-11 |
| DE69619117T2 (de) | 2002-09-19 |
| DE69619117D1 (de) | 2002-03-21 |
| CN1192148A (zh) | 1998-09-02 |
| WO1997004785A1 (en) | 1997-02-13 |
| HK1015686A1 (en) | 1999-10-22 |
| DK0845991T3 (da) | 2002-05-27 |
| CN1091601C (zh) | 2002-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT845991E (pt) | Utilizacao de difosfonatos substituidos com fenol como agentes anti-neoplasicos | |
| TR200100672T2 (tr) | Yeni izoksazolinon antibakteriyel ajanları | |
| BR0007527A (pt) | Fenilfenantridinas com atividade inibitória depde-iv | |
| BR0015110A (pt) | Métodos de tratamento de doenças de proliferação celular, de tratamento de um distúrbio associado com a atividade da cinesina ksp, de inibição da cinesina ksp, de triagem de moduladores da cinesina kps e de triagem de compostos que se ligam na cinesina ksp, e, compostos | |
| DE69633679D1 (de) | Substituierte aryl-oder heteroarylamide mit retinoid-ähnlicher biologischer aktivität | |
| CU23126A3 (es) | Inhibicion de kinasa raf usando ureas heterociclicas sustituidas | |
| HK1026691A1 (en) | Substituted benzimidazoles and their use for treating retroviral infection | |
| RU94031102A (ru) | Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний | |
| BR9707233A (pt) | Fenantridinas | |
| ID22042A (id) | Benzonaftiridin sebagai pengobatan cabang tenggorokan | |
| ATE224386T1 (de) | Neue in 6-position substituierte phenanthridine | |
| BR9814361A (pt) | Inibição de quinase raf usando uréiasheterocìclicas substituìdas por arila eheteroarila | |
| BR9606547A (pt) | Novos derivados de pirimidona com atividade fungicida | |
| TR199700206A2 (xx) | Floralkil- ve floralkoksi ikame edilmi� heterosiklik bradikinin-antagonistleri, bunlar�n imal edilmesine mahsus usul ve bunlar�n kullan�lmalar�. | |
| BR0009101A (pt) | 9a-azalidas com atividade antibacteriana | |
| ATE215084T1 (de) | Imidazopyridin-azolidinone | |
| BR9609801A (pt) | Petídos cíclicos análogos de somatostina com atividade inibitória do desenvolvimento de hormónio | |
| BR9807785A (pt) | Processo para a preparação do composto, e, composto | |
| PT970105E (pt) | Processo para a preparacao de carboxamido-4-azasteroides | |
| SV2002000573A (es) | Proceso para preparar 2-(4-piridil) amino-6- dialquiloxifenil-pirido[2,3-d] pirimidin-7-onas | |
| BR9808210A (pt) | Befeniloxazolinas dissubstituìdas | |
| BR0008791A (pt) | Derivados anticonvulsivos, úteis no tratamento de tremor essencial | |
| SE9602416D0 (sv) | New forms of an organic salt of N'N-diacetylcystine | |
| DE69711422D1 (de) | Verwendung von (r)-verapamil als medizin zur behandlung von angina | |
| ATE209493T1 (de) | Verwendung von aspirochlorine oder dessen derivaten zur immunsuppression |